Filing Details
- Accession Number:
- 0001140361-23-017270
- Form Type:
- 13G Filing
- Publication Date:
- 2023-04-06 20:00:00
- Filed By:
- Gic Private Ltd
- Company:
- Regenxbio Inc. (NASDAQ:RGNX)
- Filing Date:
- 2023-04-07
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| GIC Private Limited | 1,616,494 | 582,020 | 1,616,494 | 582,020 | 2,198,514 | 5.1% |
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. ) *
REGENXBIO Inc.
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
75901B107
(CUSIP Number)
March 31, 2023
(Date of the Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed :
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any
subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provision of the Act (however, see the Notes.)
| SCHEDULE 13G | |
| CUSIP No. 75901B107 | Page 2 of 5 Pages |
| 1 | NAMES OF REPORTING PERSONS | | | ||
| GIC Private Limited | | | |||
| | | ||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | ||||
| (a)☐ | |||||
| (b)☐ | | | |||
| 3 | SEC USE ONLY | | | ||
| | | | |||
| | | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION | | | ||
| Republic of Singapore | | | |||
| | | ||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER | | | |
| 1,616,494 | | | |||
| | | ||||
| 6 | SHARED VOTING POWER | | | ||
| 582,020 | | | |||
| | | ||||
| 7 | SOLE DISPOSITIVE POWER | | | ||
| 1,616,494 | | | |||
| | | ||||
| 8 | SHARED DISPOSITIVE POWER | | | ||
| 582,020 | | | |||
| | | ||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | | ||
| 2,198,514 | | | |||
| | | ||||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | | | ||
| ☐ | | | |||
| | | ||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | | | ||
| 5.1% (1) | | | |||
| | | ||||
| 12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | | | ||
| CO | | | |||
| | | ||||
(1) Based on 43,463,655 Common Stock outstanding as of February 23, 2023, according to the Form 10-K filed by the Issuer with the Securities and Exchange
Commission on February 28, 2023.
| SCHEDULE 13G | |
| CUSIP No. 75901B107 | Page 3 of 5 Pages |
| Item 1(a) | Name of Issuer |
REGENXBIO Inc.
| Item 1(b) | Address of Issuer’s Principal Executive Offices |
9804 Medical Center Drive
Rockville, MD 20850
| Item 2(a) | Name of Persons Filing |
GIC Private Limited (“GIC”)
| Item 2(b) | Address of Principal Business Office or, if none, Residence |
168 Robinson Road
#37-01 Capital Tower
Singapore 068912
| Item 2(c) | Citizenship |
Singapore
| Item 2(d) | Title of Class of Securities |
Common Stock, $0.0001 par value per share
| Item 2(e) | CUSIP Number |
75901B107
| Item 3 | If this statement in filed pursuant to §§240.13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
| Item 4 | Ownership |
(a - c) The aggregate number of securities and percentage of the class of securities of the Issuer beneficially owned by the Reporting Person named in Item
2(a), as well as the number of securities as to which such person is deemed to have sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, shared power to dispose or
direct the disposition, is set forth in the following tables:
| Reporting Person | No. of Securities Beneficially Owned | Percent of Class (3) | Voting Power | Dispositive Power | ||
| Sole (1), (2) | Shared (1), (2) | Sole (1), (2) | Shared (1), (2) | |||
| GIC Private Limited | 2,198,514 | 5.1 | 1,616,494 | 582,020 | 1,616,494 | 582,020 |
| (1) | GIC is a fund manager and only has 2 clients – the Government of Singapore (“GoS”) and the Monetary Authority of Singapore (“MAS”). Under the investment management agreement with GoS, GIC
has been given the sole discretion to exercise the voting rights attached to, and the disposition of, any shares managed on behalf of GoS. As such, GIC has the sole power to vote and power to dispose of the 1,616,494 securities beneficially
owned by it. GIC shares power to vote and dispose of 582,020 securities beneficially owned by it with MAS. |
| (2) | GIC disclaims membership in a group. |
| (3) | Based on 43,463,655 Common Stock outstanding as of February 23, 2023, according to the Form 10-K filed by the Issuer with the Securities and Exchange Commission on February 28, 2023. |
| SCHEDULE 13G | |
| CUSIP No. 75901B107 | Page 4 of 5 Pages |
| Item 5 | Ownership of Five Percent or Less of a Class |
Not applicable.
| Item 6 | Ownership of More than Five Percent on Behalf of Another Person |
Not applicable.
| Item 7 | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company |
Not applicable.
| Item 8 | Identification and Classification of Members of the Group |
Not applicable.
| Item 9 | Notice of Dissolution of Group |
Not applicable.
| Item 10 | Certifications |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than
activities solely in connection with a nomination under §240.14a-11.
| SCHEDULE 13G | |
| CUSIP No. 75901B107 | Page 5 of 5 Pages |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct as dated.
| GIC PRIVATE LIMITED | ||
| By: | /s/ Glien Tan Cheng Chuan | |
| Name: Glien Tan Cheng Chuan | ||
| Title: Managing Director | ||
| Date: April 6, 2023 | ||
| By: | /s/ Toh Tze Meng | |
| Name: Toh Tze Meng | ||
| Title: Senior Vice President | ||
| Date: April 6, 2023 | ||